Results 291 to 300 of about 829,432 (354)

Presence of 4‑Hydroxy‑<i>N</i>‑methyl‑<i>N</i>‑ethyltryptamine in Commercially Available Products. [PDF]

ACS Omega
Barovic A, Pittiglio MK, Barrett JM, Aretz CDJ, Tesfatsion TT, Ramirez GA, Cruces W.   +6 more
europepmc   +1 more source

Harm to a child caused by the off-label use of prochlorperazine maleate tablets due to the discontinuation of licensed prochlorperazine mesilate liquid in the UK. [PDF]

Eur J Hosp Pharm
Morris S, Salm V, Salm A.
europepmc   +1 more source

Prussian Blue Tablets for Cesium Decorporation: pH-Dependent Performance Under Normogastric and Hypochlorhydric Conditions in an In Vitro Gastrointestinal Model. [PDF]

Pharmaceuticals (Basel)
Martínez-Alonso B, Torrado Durán G, Pardo Laurel H, Guarnizo-Herrero V, Peña Fernández MÁ.   +4 more
europepmc   +1 more source

Estimating the impact of pill burden on health utilities in hemodialysis therapy. [PDF]

Sci Rep
Shimoda H, Taniguchi M, Yamamoto S, Igarashi A, Tokunaga S, Hanada K, Tashiro N, Murata T, Asada S.   +8 more
europepmc   +1 more source

Single subconjunctival injection formulation with a 5-fluorouracil-poly(lactic) acid controlled-release system for glaucoma filtration surgery. [PDF]

Int J Ophthalmol
Zhang JJ, Gao F, Deng KX, Guan WX, Sun YY.   +4 more
europepmc   +1 more source

Developments in image-based colorimetric analysis methods and applications of CIElab color space in pharmaceutical sciences: A narrative review. [PDF]

Int J Pharm X
Marefat S, Shayanfar A, Monajjemzadeh F.
europepmc   +1 more source